Atlantic Coastal Acquisition Corp. II financial data

Symbol
ACAB, ACABU, ACABW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
6 St Johns Lane, Floor 5, New York, New York
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q4 2023 - Apr 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 67.5 % -11.8%
Debt-to-equity -161 % -45.7%
Return On Equity -19.7 % -133%
Return On Assets 2.64 % +820%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 0 USD

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -1.67 M USD +18.7%
Nonoperating Income (Expense) 5.66 M USD +50.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4 M USD +134%
Income Tax Expense (Benefit) 1.18 M USD +42.9%
Net Income (Loss) Attributable to Parent 2.82 M USD +218%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 265 K USD -32.6%
Assets, Current 30 M USD +3794%
Assets 37.4 M USD -88%
Accrued Liabilities, Current 469 K USD -62.3%
Liabilities, Current 35.4 M USD +1552%
Liabilities 45.9 M USD +263%
Retained Earnings (Accumulated Deficit) -15.8 M USD -41.5%
Stockholders' Equity Attributable to Parent -15.8 M USD -41.5%
Liabilities and Equity 37.4 M USD -88%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.85 M USD -224%
Net Cash Provided by (Used in) Financing Activities -275 M USD -189%
Net Cash Provided by (Used in) Investing Activities 278 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -128 K USD -133%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 265 K USD -32.6%
Deferred Tax Assets, Valuation Allowance 687 K USD +76.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 687 K USD +76.8%
Deferred Tax Assets, Operating Loss Carryforwards 0 USD
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -298 K USD +23.2%
Preferred Stock, Shares Authorized 1 M shares 0%
Additional Paid in Capital 0 USD
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 1.18 M USD +42.9%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%